Chongqing Key Laboratory of Big Data for Bio-Intelligence, School of Life Health Information Science and Engineering, Chongqing University of Posts and Telecommunications, Chongqing, 400065, China.
Lipids Health Dis. 2024 Nov 15;23(1):378. doi: 10.1186/s12944-024-02369-6.
Cellular carcinogenesis is often marked by the accumulation of lipid droplets (LDs) due to reprogrammed lipid metabolism. LDs are dynamic organelles that primarily store intracellular triacylglycerol (TAG) and cholesteryl esters (CEs). Transmembrane protein 68 (TMEM68), a potential modifier of human breast cancer risk and outcomes, functions as a diacylglycerol acyltransferase, synthesizing TAG. However, the specific roles of TMEM68 in breast cancer cells remain unclear.
Gene expression profiling interactive analysis and survival analysis were conducted. TMEM68 was overexpressed or knockdown in breast cancer cells to assess its impact on cell proliferation, migration and invasion. Targeted quantitative lipidomic analysis and quantitative polymerase chain reaction were used to profile lipid alterations and examine gene expression related to lipid metabolism following changes in TMEM68 levels.
TMEM68 gene was upregulated in breast cancer patients and higher TMEM68 levels were associated with poorer survival outcomes. Overexpression of TMEM68 increased breast cancer cell proliferation and invasion, whereas knockdown had minimal or no impact on reducing proliferation and invasion. Altering TMEM68 levels resulted in corresponding changes in TAG levels and cytoplasmic LDs, with overexpression increasing both and knockdown decreasing them. Lipidomic analysis revealed that TMEM68 regulated TAG levels and altered diacylglycerol content in breast cancer cells. Additionally, TMEM68 influenced the metabolism of glycerophospholipids, CEs and acylcarnitines. TMEM68 also modified the expression of key genes encoding enzymes related to neutral lipid metabolism, including TAG and CEs.
TMEM68 is highly expressed in breast cancer and negatively correlated with survival. Its overexpression promotes breast cancer cell proliferation while knockdown has varied effects depending on TMEM68 levels. TMEM68 regulates intracellular TAG and LDs contents along with alterations in glycerophospholipids. These findings suggest that TMEM68 may drive breast cancer cells proliferation by modulating TAG and LD content.
细胞癌变通常由于脂质代谢重编程而导致脂滴(LDs)积累。LDs 是动态细胞器,主要储存细胞内三酰基甘油(TAG)和胆固醇酯(CE)。跨膜蛋白 68(TMEM68)是一种潜在的人类乳腺癌风险和预后的修饰物,作为二酰基甘油酰基转移酶发挥作用,合成 TAG。然而,TMEM68 在乳腺癌细胞中的具体作用尚不清楚。
进行基因表达谱交互分析和生存分析。在乳腺癌细胞中过表达或敲低 TMEM68,以评估其对细胞增殖、迁移和侵袭的影响。靶向定量脂质组学分析和定量聚合酶链反应用于分析 TMEM68 水平变化后脂质变化,并研究与脂质代谢相关的基因表达。
TMEM68 基因在乳腺癌患者中上调,较高的 TMEM68 水平与较差的生存结局相关。过表达 TMEM68 增加乳腺癌细胞的增殖和侵袭,而敲低则对减少增殖和侵袭几乎没有影响或没有影响。改变 TMEM68 水平会导致 TAG 水平和细胞质 LDs 的相应变化,过表达会增加这两者,而敲低则会减少它们。脂质组学分析表明,TMEM68 调节乳腺癌细胞中的 TAG 水平和二酰基甘油含量。此外,TMEM68 还影响甘油磷脂、CE 和酰基辅酶 A 的代谢。TMEM68 还改变了编码与中性脂质代谢相关的关键酶的基因的表达,包括 TAG 和 CE。
TMEM68 在乳腺癌中高度表达,与生存呈负相关。其过表达促进乳腺癌细胞增殖,而敲低则根据 TMEM68 水平产生不同的影响。TMEM68 调节细胞内 TAG 和 LDs 含量以及甘油磷脂的变化。这些发现表明,TMEM68 可能通过调节 TAG 和 LD 含量来驱动乳腺癌细胞的增殖。